UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Top court rejects financial regulator’s retry to discipline Samsung BioLogics
The Financial Services Commission (FSC)'s disciplinary action against S...
by Jeong Sae-im
|
2019-09-10 14:36
라인
Canada OKs Celltrion's biosimilar
Celltrion said that Health Canada has given the go-ahead for Herzuma (Ingre...
by Lee Han-soo
|
2019-09-10 12:48
라인
Samsung Bioepis launches Enbrel biosimilar in Brazil
Samsung Bioepis said that it has received sales approval for Brenzys, an En...
by Lee Han-soo
|
2019-09-10 12:21
라인
Invossa victims furious at government, Kolon for ‘doing nothing’
“We’ve never heard when and how they would do a long-term follow-up. Kolon ...
by Jeong Sae-im
|
2019-09-09 15:47
라인
Nobel laureate Honjo anticipates best combo in immunotherapies
Professor Tasuku Honjo of Kyoto University said he was expecting a good out...
by Jeong Sae-im
|
2019-09-06 16:29
라인
Change in licensing-out contract may be bad sign for Intron Biotechnology
Intron Biotechnology said the conditions for last November’s deal with a mu...
by Jeong Sae-im
|
2019-08-30 14:47
라인
Huons, Prestige Bio to develop biosimilars
Huons said that it plans to enter the biosimilar market by collaborating wi...
by Lee Han-soo
|
2019-08-28 16:05
라인
New way found to heal wounds of autoimmune disease patients
Korean researchers have found a new method to quickly heal the wounds of pa...
by Song Soo-youn
|
2019-08-28 15:19
라인
‘GI Innovation will be small but strong leader of bioindustry’
“GI Innovation, armed with both basic science and development strategy, wil...
by Kim Yun-mi
|
2019-08-27 15:57
라인
Invossa victims, Kolon shareholders demand apology, compensation
After the Korea Exchange’s Corporate Review Committee decided to delist Kol...
by Jeong Sae-im
|
2019-08-27 15:40
라인
Regulator decides to delist Kolon TissueGene
Kolon TissueGene, an affiliate of Kolon Life Science, is on the verge of be...
by Jeong Sae-im
|
2019-08-27 12:15
라인
Medipost’s Pneumostem gets FDA’s fast-track designation
Medipost said that the U.S. Food and Drug Administration has given a fast- ...
by Lee Han-soo
|
2019-08-23 17:51
라인
GenNBio to test transplanting pig’s pancreatic islet into human next year
GenNBio said it would officially enter the market of transplanting organs f...
by Jeong Sae-im
|
2019-08-23 13:53
라인
Japan gives further nod to Celltrion's breast cancer biosimilar
Celltrion Healthcare said that Japan's Ministry of Health, Labour and W...
by Lee Han-soo
|
2019-08-22 16:47
라인
Pharmicell submits new drug application for ovarian cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo
|
2019-08-19 13:10
라인
Stock exchange names Kolon Life Science as administrative issue
Kolon Life Science, once one of the most promising bio-stocks, has been dow...
by Lee Han-soo
|
2019-08-16 16:49
라인
Medipost’s stem cell therapy, cord blood bank show solid growth
Medipost’s stem cell therapy Cartistem for osteoarthritis and umbilical cor...
by Jeong Sae-im
|
2019-08-16 16:18
라인
CHA Biotech wins patent for placenta-derived mesenchymal stem cells
CHA Biotech said that it has obtained a patent for the use of placenta-deri...
by Lee Han-soo
|
2019-08-12 18:24
라인
Samsung BioLogics implants cell-culturing tech
Samsung BioLogics said that it has implanted a new cell-culturing technolog...
by Lee Han-soo
|
2019-08-12 16:05
라인
Injectable hydrogels developed to raise stem cell survival rate
Korean researchers have developed a technology of scaffolding stem cells wi...
by Song Soo-youn
|
2019-08-12 15:18
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top